About Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. engages in the research and development of medicines in the areas of antineoplastic, diabetes, cardiovascular, bio-pharmaceutical, and the immune system. It develops Apatinib, an anti-angiogenesis medicine that treats patients suffering from late stage gastric cancer. The company produces and sells injectable products, oral dosages, and other types of medicines in the European and the United States markets. Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang, China.